Korean biopharmaceutical companies are exploring opportunities at Bio Japan 2024 amid U.S.-China tensions, with major firms ...

Lenacapavir is already in use as a treatment for HIV. However, pharma giant Gilead has been testing it as an injectable form ...

Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and ...

In a significant legal development, the U.S. Supreme Court has denied Martin Shkreli’s appeal to overturn a $64.6 million ...

More than the Q2 results, Mohit Khanna believes the more important aspect would-be management commentary regarding the ...

The Medicare plan by Biden and Harris is a political bribe aimed at securing the votes of Americans aged 65 and over, critics ...

The Supreme Court rejected appeals in high-profile cases regarding singer R. Kelly, Martin Shkreli and a former Texas police ...

The Supreme Court on Monday rejected an appeal from Martin Shkreli, who was once dubbed “Pharma Bro” afterjacking up the ...

The Supreme Court declined on Monday to hear an appeal from R. Kelly, who is currently serving a prison sentence for federal ...

Finolex Industries Ltd, Astrazeneca Pharma India Ltd, Macrotech Developers Ltd and JK Lakshmi Cement Ltd are among the other gainers in the BSE's 'A' group today, 07 October 2024.

AstraZeneca Pharma India Managing Director and Country President, Sanjeev Panchal, talks to Shine Jacob about the company's ...

Similarly, the DSES, the index that represents Shariah-based companies, went down by 30.41 points or 2.49 percent to 1,190 ...